Results 1 to 10 of about 23,829 (182)
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Monkeypox virus (MPXV) is gaining attention in the global health community due to its potential for human transmission and similarities to the well‐known smallpox virus. Mpox was first detected in the 1970s and mostly affects Central and West Africa.
Muslim Bin Aqeel +5 more
wiley +1 more source
Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.ABSTRACT Congenital cytomegalovirus (CMV) is a known cause of childhood‐onset disability. Australian guidelines recommend all pregnant women be informed about CMV risk‐reduction strategies. We conducted semi‐structured interviews with six Australian General Practitioners (GPs) who had completed a CMV eLearning module to explore their education ...
Natalia Rode +5 more
wiley +1 more source
Clinical Utility of Stillbirth Investigations in Australia: A Cohort Study
Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.ABSTRACT Background Stillbirths impact over two million parents globally every year. Despite current knowledge, technology, and investigations, many stillbirths remain unexplained and are not fully investigated. An important step forward in addressing this gap is determining which investigations produce the highest utility in identifying the cause of ...
Tania Marsden +22 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 1064-1074, June 2026.In a pilot randomized clinical trial of cesarean‐born infants, vaginal microbiota transfer improved social–emotional development at 12 months, reducing social–emotional risk and improving key subdomains, while early neurodevelopmental benefits observed at 6 months were not sustained at 12 months. Abstract Introduction To evaluate the effects of vaginal
Chuhui Zhou +9 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 999-1016, June 2026.Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu +3 more
wiley +1 more source
GLUT1 Deficiency Syndrome with Coexistent Movement Disorder and Anemia
Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan +12 more
wiley +1 more source
A Novel PLP1 Gene Mutation Causing Hereditary Spastic Paraplegia Type 2: A Case Report
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT We report a case of a female patient with hereditary spastic paraplegia type 2 (SPG2), who harbors a novel heterozygous nonsense mutation (c.166C>T/p.Gln56*) in the proteolipid protein 1 (PLP1) gene, which has been previously unpublished in the literature. This discovery expands the spectrum of pathogenic mutations in the PLP1 gene.
Qiaoling Tan, Wei Dong
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
Early congenital syphilis [PDF]
Canadian Medical Association Journal, 2007 Since the publication of our recent public health article about early congenital syphilis,[1][1] we have been able to obtain patient consent for publication of photographs and details pertaining to 2 pregnant women who delivered babies with congenital syphilis.
Ameeta Eshri, Singh +4 more
openaire +2 more sources
The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 5, May 2026.ABSTRACT Background The evidence gap relating to the risk of congenital anomalies (CA) associated with first trimester medication exposure in pregnancy is well recognized. Aims We describe the EUROmediCAT network and databases, and the methodological approach to pregnancy pharmacovigilance.
Helen Dolk +27 more
wiley +1 more source